(Q57911490)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802249%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

EPO's rescue mission in acute myocardial infarction: still more hopes than evidence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802249%20AND%20SRC:MED&resulttype=core&format=json

acute myocardial infarction

13 February 2020

main subject

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802249%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ewa A Jankowska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802249%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

2

E. A. Jankowska

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20802249

3 July 2024

publication date

29 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802249%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

published in

European Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802249%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802249%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802249%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

2577-2579

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802249%20AND%20SRC:MED&resulttype=core&format=json

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

13 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

The timing of development and subsequent clinical course of heart failure after a myocardial infarction.

3 July 2024

2

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.

3 July 2024

3

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization

3 July 2024

4

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Protective effects of erythropoietin in cardiac ischemia: from bench to bedside

3 July 2024

5

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

New avenues of exploration for erythropoietin

3 July 2024

6

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Erythropoietin: physiology and molecular mechanisms

3 July 2024

7

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion

3 July 2024

8

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.

3 July 2024

9

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.

3 July 2024

10

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure

3 July 2024

11

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

3 July 2024

12

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

A novel protective effect of erythropoietin in the infarcted heart

3 July 2024

13

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit

3 July 2024

14

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties.

3 July 2024

15

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

3 July 2024

16

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study

3 July 2024

17

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction

3 July 2024

18

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA.

3 July 2024

19

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -.

3 July 2024

20

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

A single dose of erythropoietin in ST-elevation myocardial infarction

3 July 2024

21

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Speckle tracking imaging improves in vivo assessment of EPO-induced myocardial salvage early after ischemia-reperfusion in rats

3 July 2024

22

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

3 July 2024

23

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Erythropoietin therapy for acute stroke is both safe and beneficial

3 July 2024

24

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Recombinant human erythropoietin in the treatment of acute ischemic stroke

3 July 2024

25

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Erythropoiesis-stimulating agents--time for a reevaluation

3 July 2024

26

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)

3 July 2024

27

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHQ307

3 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802249%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference